United Kingdom

People: Bioanalytical Systems Inc (BASI.OQ)

BASI.OQ on NASDAQ Stock Exchange Capital Market

23 Aug 2019
Change (% chg)

$-0.08 (-2.88%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Leasure, Robert 

Mr. Robert Leasure is President, Chief Executive Officer, Director of the company. Since September of 2016, Mr. Leasure has worked closely with the Company's management team and board of directors to guide operations and assist BASi in restructuring and developing a growth strategy for the Company. Mr. Leasure's experience leading the Company's turnaround, including the Company's refinancing, its acquisition of Seventh Wave Laboratories, Inc., and its execution of expansion and growth plans over the last two years, ideally positions him for the role of President and Chief Executive Officer and as a director. BASi's board believes Mr. Leasure's demonstrated successes, experience, ability to develop and work collaboratively with the management team, and his ability to create and execute upon visions for the future of the Company have been, and will continue to be, critical to growing the Company's business and creating long-term shareholder value.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --